Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Prevention Science : the Official Journal of the Society for Prevention Research|July 7, 2022
What Works for Whom in School-Based Anti-bullying Interventions? An Individual Participant Data Meta-analysisMaud Hensums, Brechtje de Mooij, Steven C Kuijper, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 11, 2025
Trastuzumab Deruxtecan Versus Ramucirumab-Paclitaxel as Second-Line Therapy for Patients With HER2-Positive Gastric or GEJ AdenocarcinomaRob H A Verhoeven, Steven C Kuijper, Florian Lordick, et al.International Journal of Cancer|December 1, 2022
SOURCE beyond first-line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first-line palliative systemic therapySteven C Kuijper, Marieke Pape, Nadia Haj Mohammad, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Beyond Median Overall Survival: Estimating Trends for Multiple Survival Scenarios in Patients With Metastatic Esophagogastric CancerMarieke Pape, Steven C Kuijper, Pauline A J Vissers, et al.International Journal of Cancer|February 25, 2023
Conditional relative survival in nonmetastatic esophagogastric cancer between 2006 and 2020: A population-based studyMarieke Pape, Steven C Kuijper, Pauline A J Vissers, et al.Therapeutic Advances in Medical Oncology|June 8, 2026
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based studySebastiaan N Siegerink, Steven C Kuijper, Tom van den Ende, et al.International Journal of Cancer|September 23, 2025
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer: A real-world matched comparison of overall survivalRob H A Verhoeven, Steven C Kuijper, Marije Slingerland, et al.International Journal of Cancer|March 1, 2023
Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: A population-based studySteven C Kuijper, Marieke Pape, Pauline A J Vissers, et al.Acta Oncologica (Stockholm, Sweden)|June 2, 2022
Improving survival prediction of oesophageal cancer patients treated with external beam radiotherapy for dysphagiaPaul M Jeene, Steven C Kuijper, Héctor G van den Boorn, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 3, 2026
Predicting health-related quality of life for patients with gastroesophageal cancerSteven C Kuijper, Irene Cara, Gijs Geleijnse, et al.Pageof 2